PPARA and metabolic dysfunction-associated steatotic liver disease: In summary, our findings position 10-HSA as a strong microbial biotherapeutic candidate to preserve homeostasis across the gut-liver axis through activation of PPARα and FAM repair in multiple NAFLD.